Tenelia M Sustained-release Tablet 10/500 mg

Adult dose

This medication is generally administered once daily with the evening meal, with dosage adjusted gradually. The 20/1000 mg sustained-release tablet is taken once daily, 1 tablet at a time. The 10/750 mg or 10/500 mg sustained-release tablets are taken once daily, with 2 tablets taken simultaneously. The initial dosage should provide Teneligliptin 20 mg once daily and the established dosing of Metformin. The maximum recommended dosage per day is

This medication aids in controlling blood sugar, but a rare side effect known as severe lactic acidosis may occur in some patients. This side effect can be particularly risky for those with impaired kidney function or those with heart disease, sepsis, etc. This medication should not be given to patients with moderate to severe impairment of kidney function, heart failure, acute myocardial infarction, or sepsis. Additionally, the use of this medication should be temporarily suspended before and after examinations using iodinated contrast agents, and patients with liver dysfunction or pregnant women should avoid its use. When used in conjunction with other medications for diabetes treatment, the risk of hypoglycemia may increase, so patients should be well-informed about the symptoms of hypoglycemia and may need to adjust dosages of other medications as necessary. During treatment, kidney function and liver function should be regularly monitored to ensure there are no abnormalities, and vitamin B12 levels may decrease, so monitoring is advisable. During this medication, dehydration, severe vomiting or diarrhea, acute infections, and before and after surgery should lead to temporary discontinuation of its use, and if sudden abdominal pain or vomiting occurs, which may suggest pancreatitis, immediate consultation with healthcare professionals is necessary. Alcohol consumption may increase the risk of lactic acidosis, so it is important not to overindulge during treatment. Particularly, caution is needed for the elderly or those with reduced kidney function, and patients and families should be adequately informed of symptoms of hypoglycemia or lactic acidosis that may occur with this medication. Finally, this medication has not established safety and efficacy in children, so it is advisable not to use it.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, abnormal breathing accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe malaise, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output.

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• abdominal distension
• abdominal pain
• nausea
• stomatitis
• gastritis
• diarrhea
• loss of appetite

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius to preserve the medication's effectiveness for a long time.

Appearance

Orange egg-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle